Literature DB >> 7057125

Phencyclidine discrimination in the pigeon using color tracking under second-order schedule.

D E McMillan, D A Cole-Fullenwider, W C Hardwick, G R Wenger.   

Abstract

Pigeons were trained to track different key colors, depending on whether they had been injected with phencyclidine or saline prior to the session. A second-order schedule was used to generate large numbers of responses prior to the initial food delivery. The procedure offers several advantages over traditional procedures for studying drug discrimination.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7057125      PMCID： PMC1333125          DOI： 10.1901/jeab.1982.37-143

Source DB:  PubMed          Journal:  J Exp Anal Behav        ISSN： 0022-5002            Impact factor:   2.468


  6 in total

1.  A comparison of the discriminable CNS effects of ketamine, phencyclidine and pentobarbital.

Authors:  D A Overton
Journal:  Arch Int Pharmacodyn Ther       Date:  1975-06

2.  Response variability in the white rat during conditioning, extinction, and reconditioning.

Authors:  J J ANTONITIS
Journal:  J Exp Psychol       Date:  1951-10

3.  Measurement of stimulus control during discriminative operant conditioning.

Authors:  H M Jenkins
Journal:  Psychol Bull       Date:  1965-11       Impact factor: 17.737

4.  Inter-animal olfactory cues in operant drug discrimination procedures in rats.

Authors:  K Extance; A J Goudie
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

5.  Drug discrimination in rats: the effects of phencyclidine and ditran.

Authors:  T U Järbe; J O Johansson; B G Henriksson
Journal:  Psychopharmacologia       Date:  1975-04-30

6.  Phencyclidine-like discriminative effects of opioids in the rat.

Authors:  S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1980-09       Impact factor: 4.030
  6 in total
  17 in total

1.  Drug discrimination under a concurrent fixed-ratio fixed-ratio schedule.

Authors:  D E McMillan; M Li
Journal:  J Exp Anal Behav       Date:  1999-09       Impact factor: 2.468

2.  Drug discrimination under concurrent variable-ratio variable-ratio schedules.

Authors:  D E McMillan; W C Hardwick; Mi Li
Journal:  J Exp Anal Behav       Date:  2002-01       Impact factor: 2.468

3.  Effects of amphetamine-CNS depressant combinations and of other CNS stimulants in four-choice drug discriminations.

Authors:  Mi Li; William D Wessinger; D E McMillan
Journal:  J Exp Anal Behav       Date:  2005-07       Impact factor: 2.468

4.  Effects of schedule of reinforcement on a pentobarbital discrimination in rats.

Authors:  S H Snodgrass; D E McMillan
Journal:  J Exp Anal Behav       Date:  1991-09       Impact factor: 2.468

5.  Drug discrimination under a concurrent fixed-interval fixed-interval schedule.

Authors:  D E McMillan; M Li; W C Hardwick
Journal:  J Exp Anal Behav       Date:  1997-09       Impact factor: 2.468

6.  Effects of single or multiple choice trials per session on drug discrimination performance.

Authors:  A Tomie; L Peoples; G C Wagner
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

7.  Drug discrimination training with a single choice trial per session.

Authors:  A Tomie; E Loukas; I Stafford; L Peoples; G C Wagner
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 8.  Trends in drug discrimination research analysed with a cross-indexed bibliography, 1982-1983.

Authors:  I P Stolerman; P J Shine
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

9.  Effects of barbiturates and other sedative hypnotics in pigeons trained to discriminate phencyclidine from saline.

Authors:  D E McMillan; G R Wenger
Journal:  J Exp Anal Behav       Date:  1983-09       Impact factor: 2.468

10.  Drug effects on repeated acquisition: comparison of cumulative and non-cumulative dosing.

Authors:  D M Thompson; J M Moerschbaecher; P J Winsauer
Journal:  J Exp Anal Behav       Date:  1983-01       Impact factor: 2.468
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.